# FGGY

## Overview
The FGGY gene encodes a protein that belongs to the FGGY family of carbohydrate kinases, which are integral to the phosphorylation of sugars, a vital process in carbohydrate metabolism. The protein encoded by the FGGY gene functions primarily as a D-ribulokinase, catalyzing the conversion of D-ribulose to D-ribulose-5-phosphate, a critical step in the pentose phosphate pathway. This pathway is essential for nucleotide synthesis and maintaining redox balance within cells (Singh2017Molecular). The FGGY protein operates in the cytoplasm, where it plays a crucial role in converting sugars into metabolically useful forms, thereby supporting cellular metabolic balance and glycosylation processes (Singh2017Molecular). Additionally, the protein's involvement in metabolite repair processes underscores its importance in preserving cellular homeostasis. The FGGY gene's expression and function have been linked to various clinical conditions, highlighting its significance in both normal physiology and disease states.

## Structure


## Function
The FGGY gene encodes a protein that is part of the FGGY family of carbohydrate kinases, which are involved in the phosphorylation of sugars, a critical step in carbohydrate metabolism. In healthy human cells, the FGGY protein functions primarily as a D-ribulokinase, catalyzing the conversion of D-ribulose to D-ribulose-5-phosphate in the presence of ATP. This reaction is a key step in the metabolism of pentitols, such as ribitol, and is part of the pentose phosphate pathway, which is crucial for cellular processes like nucleotide synthesis and redox balance (Singh2017Molecular).

The FGGY protein is active in the cytoplasm, where it facilitates the conversion of sugars into forms that can be further utilized in cellular metabolic pathways. This activity is essential for maintaining metabolic balance and supporting glycosylation processes, which are important for cell structure and function (Singh2017Molecular). The protein's role in sugar metabolism is also linked to its potential involvement in metabolite repair processes, where it may help preserve the D-ribulose-5-phosphate pool and prevent the accumulation of free D-ribulose, which could be toxic to cells (Singh2017Molecular).

## Clinical Significance
Alterations in the expression of the FGGY gene have been implicated in several diseases and conditions. In hepatocellular carcinoma (HCC), circFGGY, a circular RNA derived from the FGGY gene, is significantly downregulated in tumor tissues compared to normal liver tissues. This downregulation is associated with poorer overall survival in HCC patients, suggesting a role in the pathogenesis of the disease (Feng2022CircFGGY).

Prenatal exposure to bisphenol A (BPA) has been shown to disrupt DNA methylation patterns at the promoter of the FGGY gene in mice, leading to increased mRNA expression. This alteration is linked to obesity-related phenotypes, such as increased body weight and gonadal fat weight, particularly in male mice. The study suggests that the FGGY gene is involved in the development of obesity following prenatal BPA exposure (Taylor2017Prenatal).

In the context of bipolar disorder, rare mutations in the FGGY gene have been identified. These mutations are associated with the modulation of intracellular signaling pathways, such as ERK/MAPK and CREB-regulated pathways, which are implicated in bipolar disorder and potentially other related conditions (Kerner2013Rare).

## Interactions
The FGGY gene encodes a protein that contains a carbohydrate kinase domain, which is involved in the phosphorylation of sugars. This protein is known to participate in various interactions within metabolic pathways, potentially forming complexes or engaging in regulatory interactions with other proteins. These interactions can significantly influence cellular processes such as glycolysis and energy metabolism. The FGGY protein may interact with enzymes or regulatory proteins, suggesting its role in modulating metabolic pathways through these associations. While specific interaction partners are not detailed in the provided context, the involvement of FGGY in these pathways implies that it could interact with key enzymes involved in carbohydrate metabolism, possibly affecting their activity or stability. These interactions may be transient or part of more stable multiprotein complexes, contributing to the regulation of metabolic fluxes within the cell. The precise nature and identity of these interaction partners remain to be elucidated, but the potential for FGGY to influence metabolic processes through these interactions highlights its importance in cellular energy homeostasis.


## References


[1. (Singh2017Molecular) Charandeep Singh, Enrico Glaab, and Carole L. Linster. Molecular identification of d-ribulokinase in budding yeast and mammals. Journal of Biological Chemistry, 292(3):1005–1028, January 2017. URL: http://dx.doi.org/10.1074/jbc.M116.760744, doi:10.1074/jbc.m116.760744. This article has 26 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M116.760744)

[2. (Kerner2013Rare) Berit Kerner, Aliz R. Rao, Bryce Christensen, Sugandha Dandekar, Michael Yourshaw, and Stanley F. Nelson. Rare genomic variants link bipolar disorder with anxiety disorders to creb-regulated intracellular signaling pathways. Frontiers in Psychiatry, 2013. URL: http://dx.doi.org/10.3389/fpsyt.2013.00154, doi:10.3389/fpsyt.2013.00154. This article has 56 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fpsyt.2013.00154)

[3. (Taylor2017Prenatal) Julia A Taylor, Keiko Shioda, Shino Mitsunaga, Shiomi Yawata, Brittany M Angle, Susan C Nagel, Frederick S vom Saal, and Toshi Shioda. Prenatal exposure to bisphenol a disrupts naturally occurring bimodal dna methylation at proximal promoter of fggy, an obesity-relevant gene encoding a carbohydrate kinase, in gonadal white adipose tissues of cd-1 mice. Endocrinology, 159(2):779–794, December 2017. URL: http://dx.doi.org/10.1210/en.2017-00711, doi:10.1210/en.2017-00711. This article has 40 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1210/en.2017-00711)

[4. (Feng2022CircFGGY) Kun-Liang Feng, Na Diao, Zhai-Wen Zhou, Chong-Kai Fang, Ji-Nan Wang, Ying Zhang, Rui Luo, and Chong Zhong. Circfggy inhibits cell growth, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma via regulating the mir-545-3p/smad7 axis. Frontiers in Cell and Developmental Biology, May 2022. URL: http://dx.doi.org/10.3389/fcell.2022.850708, doi:10.3389/fcell.2022.850708. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2022.850708)